MIRZOTAMAB

UNII:	4L7K3H1YON
Formula:
Preferred Substance Name:	MIRZOTAMAB
GSRS Full Record:	4L7K3H1YON i

2229859-11-2
IMMUNOGLOBULIN G1 (234-ALANINE,235-ALANINE), ANTI-(HUMAN B7 HOMOLOG 3 PROTEIN) (HUMAN MONOCLONAL PR-1651850 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PR-1651850 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD276 ANTIGEN (4IG-B7-H3, B7 HOMOLOG 3, COSTIMULATORY MOLECULE)), MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN CHIMERIC(1-446) (VH (MUS MUSCULUS IGHV3-1*02 (87%) (IGHD)-IGHJ2*01 (87%)/HOMO SAPIENS IGHV4-38-2*01 (84%) (IGHD)-IGHJ4*01 (87%)) (9.7.9) (1-116)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(213))),CH3(E16>D(155),M18>L(157))) (117-446)) (219-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED(1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (82%) IGKJ2*02) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHO CELLS, GLYCOFORM ALFA
MIRZOTAMAB [INN]
MIRZOTAMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MIRZOTAMAB

Synonyms and Mappings

Resources